Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H32O2 |
Molecular Weight | 256.4241 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCC(O)=O
InChI
InChIKey=IPCSVZSSVZVIGE-UHFFFAOYSA-N
InChI=1S/C16H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H,17,18)
Molecular Formula | C16H32O2 |
Molecular Weight | 256.4241 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/26393565Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/12496284 | https://www.ncbi.nlm.nih.gov/pubmed/14717706 | https://www.ncbi.nlm.nih.gov/pubmed/18511927 | https://www.ncbi.nlm.nih.gov/pubmed/23406428
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26393565
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/12496284 | https://www.ncbi.nlm.nih.gov/pubmed/14717706 | https://www.ncbi.nlm.nih.gov/pubmed/18511927 | https://www.ncbi.nlm.nih.gov/pubmed/23406428
Palmitic acid is a saturated fatty acid, the principal constituent of refined palm oil, present in the diet and synthesized endogenously. Palmitic acid is able to activate the orphan G protein-coupled receptor GPR40. Palmitic acid was also a weak ligand of peroxisome proliferator-activated receptor gamma. Palmitic acid is a ligand of lipid chaperones - the fatty acid-binding proteins (FABPs). Dietary palm oil and palmitic acid may play a role in the development of obesity, type 2 diabetes mellitus, cardiovascular diseases and cancer.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4422 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12496284 |
5.3 null [pEC50] | ||
Target ID: CHEMBL235 Sources: https://www.ncbi.nlm.nih.gov/pubmed/14717706 |
156.0 µM [Kd] | ||
Target ID: CHEMBL3344 |
|||
Target ID: CHEMBL2083 |
|||
Target ID: CHEMBL3674 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | SURFAXIN Approved UseSURFAXIN is indicated for the prevention of respiratory distress syndrome
(RDS) in premature infants at high risk for RDS. Launch Date2012 |
PubMed
Title | Date | PubMed |
---|---|---|
Identification of fatty acid molecules in a Fasciola hepatica immunoprophylactic fatty acid-binding protein. | 2001 Apr |
|
Effects of authentic and VLDL hydrolysis-derived fatty acids on vascular smooth muscle cell growth. | 2001 Apr |
|
Carotenoid esters in vegetables and fruits: a screening with emphasis on beta-cryptoxanthin esters. | 2001 Apr |
|
Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion? | 2001 Apr |
|
Lysosomal-type PLA2 and turnover of alveolar DPPC. | 2001 Apr |
|
Pulmonary surfactant protein SP-B is significantly more immunoreactive in anionic than in zwitterionic bilayers. | 2001 Apr 13 |
|
Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha aopototic signaling. | 2001 Apr 13 |
|
Thioacylation is required for targeting G-protein subunit G(o1alpha) to detergent-insoluble caveolin-containing membrane domains. | 2001 Apr 15 |
|
Regulation of surfactant-like particle secretion by Caco-2 cells. | 2001 Apr 2 |
|
Tolerance induction by acylated peptides: suppression of EAE in the mouse with palmitoylated PLP peptides. | 2001 Apr 2 |
|
Kinetics of the lipase-catalyzed synthesis of glucose esters in acetone. | 2001 Apr 20 |
|
Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. | 2001 Apr 27 |
|
A stearic acid-rich diet improves thrombogenic and atherogenic risk factor profiles in healthy males. | 2001 Feb |
|
Fatty acid-induced apoptosis in neonatal cardiomyocytes: redox signaling. | 2001 Feb |
|
Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. | 2001 Feb |
|
DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. | 2001 Feb |
|
The growth inhibitory effect of conjugated linoleic acid on a human hepatoma cell line, HepG2, is induced by a change in fatty acid metabolism, but not the facilitation of lipid peroxidation in the cells. | 2001 Feb 26 |
|
OspA, a lipoprotein antigen of the obligate intracellular bacterial pathogen Piscirickettsia salmonis. | 2001 Jan |
|
Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. | 2001 Jan |
|
Characterization of a novel triphosphonooctaosylceramide from the eggs of the sea hare, Aplysia kurodai. | 2001 Jan |
|
Functional analysis of mutant human carnitine acylcarnitine translocases in yeast. | 2001 Jan 26 |
|
Determination of retinoids in galenicals by column liquid chromatography with fluorescence and diode-array detection. | 2001 Jan 5 |
|
Insulin inhibits peroxisomal fatty acid oxidation in isolated rat hepatocytes. | 2001 Jun |
|
Anaerobic biodegradation of alkanes by enriched consortia under four different reducing conditions. | 2001 Mar |
|
Optimization of methods and treatment conditions for studying effects of fatty acids on cell growth. | 2001 Mar |
|
Effects of diets enriched in n-6 or n-3 fatty acids on cholesterol metabolism in older rats chronically fed a cholesterol-enriched diet. | 2001 Mar |
|
JlpA, a novel surface-exposed lipoprotein specific to Campylobacter jejuni, mediates adherence to host epithelial cells. | 2001 Mar |
|
Purification and characterization of the fatty acid synthase from Bugula neritina. | 2001 Mar |
|
Development and characterization of an animal model of carnitine deficiency. | 2001 Mar |
|
Palmitoylation of the luteinizing hormone/human chorionic gonadotropin receptor regulates receptor interaction with the arrestin-mediated internalization pathway. | 2001 Mar |
|
Role of fatty acids in the recovery of cardiac function during resuscitation from hemorrhagic shock. | 2001 Mar |
|
Macrophages transfer [14C]-labelled fatty acids to pancreatic islets in culture. | 2001 Mar |
|
Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. | 2001 Mar |
|
Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart. | 2001 Mar |
|
Regulation of G proteins by covalent modification. | 2001 Mar 26 |
|
Bowman-Birk protease inhibitor and its palmitic acid conjugate prevent 7,12-dimethylbenz[a]anthracene-induced transformation in cultured mouse mammary glands. | 2001 Mar 26 |
|
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. | 2001 Mar 30 |
|
Molecular dynamics simulations of stratum corneum lipid models: fatty acids and cholesterol. | 2001 Mar 9 |
|
[Branched alkanes and other apolar compounds produced by the cyanobacterium Microcoleus vaginatus from the Negev desert]. | 2001 Mar-Apr |
|
Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. | 2001 May |
|
Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. | 2001 May |
|
Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability. | 2001 May |
|
Imaging of monolayers composed of palmitic acid and lung surfactant protein B. | 2001 May |
|
A high-sucrose diet increases gluconeogenic capacity in isolated periportal and perivenous rat hepatocytes. | 2001 May |
|
n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. | 2001 May |
|
Palmitoylation of caveolin-1 in endothelial cells is post-translational but irreversible. | 2001 May 11 |
|
Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography. | 2001 May 15 |
|
Biochemical characterization of the reverse activity of rat brain ceramidase. A CoA-independent and fumonisin B1-insensitive ceramide synthase. | 2001 May 18 |
|
Physiological levels of mammalian uncoupling protein 2 do not uncouple yeast mitochondria. | 2001 May 25 |
|
Palmitate-induced apoptosis can occur through a ceramide-independent pathway. | 2001 May 4 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18710535
The conditioned media from palmitic acid (0.2 mM) treated rat cortical astroglia, but not the cerebellar astroglia, significantly elevated levels of phosphorylated tau and BACE1 in cortical neurons as compared to controls
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:01:00 GMT 2023
by
admin
on
Fri Dec 15 15:01:00 GMT 2023
|
Record UNII |
2V16EO95H1
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
47641-6
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
NCI_THESAURUS |
C68421
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
55873-4
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
2719-3
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/04/217
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
74625-5
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
DSLD |
1603 (Number of products:186)
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
75115-6
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
NCI_THESAURUS |
C68388
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
35161-9
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
JECFA EVALUATION |
PALMITIC ACID
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
CFR |
21 CFR 172.860
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
CFR |
21 CFR 357.210
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
||
|
LOINC |
74624-8
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5030
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
LL-31
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
15756
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
1492007
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
PALMITIC ACID
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
57-10-3
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
100000091751
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
m8367
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | Merck Index | ||
|
5001
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
CHEMBL82293
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
C61873
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
1091
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
1426390
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB14744MIG
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
985
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
2V16EO95H1
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
200-312-9
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
7896
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
2V16EO95H1
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
DB03796
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
DTXSID2021602
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY | |||
|
1370621
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
ALTERNATIVE | |||
|
D019308
Created by
admin on Fri Dec 15 15:01:00 GMT 2023 , Edited by admin on Fri Dec 15 15:01:00 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
LIPID -> FATTY ACID |
Values are % of total.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
LIPID -> FATTY ACID |
Value is fatty acid composition (%) for international corn oil w/std. deviation of 1.4%
LR Strecker, et al; Proc World Conf Edible Fats & Oils Proc, Amer Oil Chem Soc, pp-309-323(1990)
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
LIPID -> FATTY ACID |
Value is % of total fatty acids.
Maiti, S, et al; Handbook of Annual Oilseed Crops, OIBH, New Delhi, India(1988), pp.1987-90
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
LIPID -> FATTY ACID |
Values given are in undefined precent.
Average is typical for U.S. Sunflower oil.
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Compound measured as 23.50% of the composition of the steam distillate of Elymus repens rhizome as per R Boesel in Planta Medica iss:4 pg:399-400, 1989.
|
||
|
SALT/SOLVATE -> PARENT | |||
|
LIPID -> FATTY ACID |
G Jurriens and ACJ Kroesen, J Am Oil Chem Soc, 42(9)(1965)(average value).
Range values as of FAO/WHO Codex Alimentarius Committee on commercial fats and oils.(unspecified percent)
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
LIPID -> FATTY ACID |
Value is fatty acid composition (%) for US corn oil w/std. deviation of 0.55%
LR Strecker, et al; Proc World Conf Edible Fats & Oils Proc, Amer Oil Chem Soc, pp-309-323(1990)
|
||
|
LIPID -> FATTY ACID |
Values are % of weight of fatty acid composition.
O?Connor, RT, Herb, SF; J Am Oil Chem Soc 47, 186A, 195A, 197A(1970)(range)
Brignoli, CA et al: J Am Diet Assoc 68, 224(1976)(average)
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
SALT/SOLVATE -> PARENT | |||
|
LIPID -> FATTY ACID |
U.S produced rice oil. Values are % of composition.
|
||
|
LIPID -> FATTY ACID |
TURKISH SOURCE
|
||
|
LIPID -> FATTY ACID |
VARIES ACCORDING TO METHOD OF EXTRACTION.
|
||
|
SALT/SOLVATE -> PARENT | |||
|
LIPID -> FATTY ACID |
Value is % of composition.
Oleic safflower variety UC-1 cited by Knowles, P, Calif. Agr. 19(12), 15(1965), produced 4.5% by composition.
|
||
|
LIPID -> FATTY ACID |
MAY BE PRESENT
USP
|
||
|
LIPID -> FATTY ACID |
Values are % of total.
|
||
|
LIPID -> FATTY ACID |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
LIPID -> FATTY ACID |
JB Rossell and co-workers; JAOCS62(2), 221-230(1985).
Range weight is a mean.
|
||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|